Unknown

Dataset Information

0

3'mRNA sequencing reveals pro-regenerative properties of c5ar1 during resolution of murine acetaminophen-induced liver injury.


ABSTRACT: Murine acetaminophen-induced acute liver injury (ALI) serves as paradigmatic model for drug-induced hepatic injury and regeneration. As major cause of ALI, acetaminophen overdosing is a persistent therapeutic challenge with N-acetylcysteine clinically used to ameliorate parenchymal necrosis. To identify further treatment strategies that serve patients with poor N-acetylcysteine responses, hepatic 3'mRNA sequencing was performed in the initial resolution phase at 24 h/48 h after sublethal overdosing. This approach disclosed 45 genes upregulated (≥5-fold) within this time frame. Focusing on C5aR1, we observed in C5aR1-deficient mice disease aggravation during resolution of intoxication as evidenced by increased liver necrosis and serum alanine aminotransferase. Moreover, decreased hepatocyte compensatory proliferation and increased caspase-3 activation at the surroundings of necrotic cores were detectable in C5aR1-deficient mice. Using a non-hypothesis-driven approach, herein pro-regenerative/-resolving effects of C5aR1 were identified during late acetaminophen-induced ALI. Data concur with protection by the C5a/C5aR1-axis during hepatectomy and emphasize the complex role of inflammation during hepatic regeneration and repair.

SUBMITTER: Gonther S 

PROVIDER: S-EPMC8795215 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

3'mRNA sequencing reveals pro-regenerative properties of c5ar1 during resolution of murine acetaminophen-induced liver injury.

Gonther Sina S   Bachmann Malte M   Goren Itamar I   Huard Arnaud A   Weigert Andreas A   Köhl Jörg J   Mühl Heiko H  

NPJ Regenerative medicine 20220127 1


Murine acetaminophen-induced acute liver injury (ALI) serves as paradigmatic model for drug-induced hepatic injury and regeneration. As major cause of ALI, acetaminophen overdosing is a persistent therapeutic challenge with N-acetylcysteine clinically used to ameliorate parenchymal necrosis. To identify further treatment strategies that serve patients with poor N-acetylcysteine responses, hepatic 3'mRNA sequencing was performed in the initial resolution phase at 24 h/48 h after sublethal overdos  ...[more]

Similar Datasets

| S-EPMC4215032 | biostudies-literature
| S-EPMC8107725 | biostudies-literature
| S-EPMC7840919 | biostudies-literature
| S-EPMC8509061 | biostudies-literature
| S-EPMC11754469 | biostudies-literature
| S-EPMC3168997 | biostudies-literature
| S-EPMC11320386 | biostudies-literature
2013-05-03 | GSE42178 | GEO
| S-EPMC6461628 | biostudies-literature
2013-05-03 | E-GEOD-42178 | biostudies-arrayexpress